Regeneron Pharmaceuticals, Inc.
REGNDividend PayerAutomated dividend-safety read-out from payout, leverage, yield, profitability and track record. See the Financials tab for the full per-statement Financial Investigation. Educational only — not investment advice.
At a glance
Regeneron Pharmaceuticals, Inc. (REGN) operates in the Biotechnology industry and is based in the United States. It pays a quarterly dividend of $3.85 a year, a yield of 0.48% at the current price of $805.02. It paid out 9% of its earnings as dividends, leaving most of its profit in the business. 28 analysts cover it; their average 12-month price target of $865.48 is 7.5% above the current price.
Written automatically from the figures on this page, as of Oct 24, 2026. Facts only, not a recommendation.
About Regeneron Pharmaceuticals, Inc.
Regeneron Pharmaceuticals, Inc. discovers, invents, develops, manufactures, and commercializes medicines to treat various diseases worldwide. The company develops product candidates to treat eye, allergic and inflammatory, cardiovascular, metabolic, neurological, infectious, and rare diseases; and cancer, hematologic conditions.
Business description sourced from Yahoo Finance / company filings. Not affiliated with SimplyWallStreet.
Key Metrics
Valuation
Profitability
Financial Health
Data provided by Yahoo Finance via yfinance. Updated daily. Not investment advice.